Vertex Rejects England’s Orkambi Offer

 
• By Francesca Bruce

Vertex has rejected the “final offer” put forward by the National Health Service in England for its cystic fibrosis drugs, including Orkambi. The company’s chief executive wants a meeting with the head of the NHS.

Form close up, fountain pen and rejected stamped on a document. Soft focus.
Vertex has said no to the NHS's final offer for its cystic fibrosis drugs

More from United Kingdom

More from Europe